ERIN DE LOS REYES: Open Payments
NPI 1174992192 · NEWNAN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$979 in 30 payments from 8 companies in 2025. Trend: 2023 $454 · 2024 $529 · 2025 $979
Food & beverage: $915Education: $64
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $357 |
| AstraZeneca Pharmaceuticals LP | 6 | $204 |
| Regeneron Healthcare Solutions, Inc. | 5 | $188 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $67 |
| GlaxoSmithKline, LLC. | 4 | $64 |
| BioCryst US Sales Co., LLC | 2 | $47 |
| Ionis Pharmaceuticals, Inc. | 1 | $37 |
| Exact Sciences Corporation | 1 | $16 |
Products named: DUPIXENT, TEZSPIRE, TAKHZYRO, NUCALA, ORLADEYO, DAWNZERA, AIRSUPRA, FASENRA.
Industry payments across GA — which companies pay providers there.
